| 產(chǎn)品名稱 | Nifedipine |
| 產(chǎn)品貨號 | Axon 2068 CAS [21829-25-4] MF C17H18N2O6MW 346.33 Purity: 99% Soluble in DMSO Description A dihydropyridine calcium channel blocker (L-type), a drug used as an anti-anginal and anti-hypertensive References Certificates Categories Extra info MJ Brown et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as (...). The Lancet, 2000, 356(9227), 366-372. ? JH Weiss et al. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science, 1990, 247(4949), 1474-1477. ? E Braunwald. Mechanism of action of calcium-channel-blocking agents. N. Engl. J. Med, 1982, 307(26), 1618. ? W Vater et al. Pharmacology of 4-(2'-nitrophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040). Arzneimittel-Forschung, 1972, 22(1), 1-14. Certificate of Analysis Material Safety Data Sheet Cardiovascular Cell Signaling & Oncology CNS Pain & Inflammation Non Selective L-Type Pfizer Licensed Products Ca2+ channel blocker (L-type voltage gated) Chemical name dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [21829-25-4] Order Size Unit Price Stock 50 mg €55.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
NifedipineAxon 2068 CAS [21829-25-4] MF C17H18N2O6
Description
A dihydropyridine calcium channel blocker (L-type), a drug used as an anti-anginal and anti-hypertensive
Ca2+ channel blocker (L-type voltage gated)
Chemical namedimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[21829-25-4] |
| 產(chǎn)品資料 |
